Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

13bg_fire_at_biocon

Major fire ravages Biocon subsidiary complex in India

December 13, 2016 Manufacturing and Production Biocon, Syngene

A subsidiary of Indian biopharmaceutical firm Biocon was gutted by a major fire at Electronic City, Bangalore on 12 December, …
News
sun_pharma

Sun Pharma’s Halol plant’s leaky roof irks FDA

December 13, 2016 Manufacturing and Production FDA, Sun Pharma, inspection

The FDA’s two week inspection of Sun Pharmaceutical’s Halol plant produced a 14-page report, with some criticisms reserved for poorly …
News
alexion_sign

Alexion loses CEO & CFO as internal investigation continues

December 12, 2016 Business Services, Manufacturing and Production, Medical Communications

Alexion Pharmaceuticals has revealed that its CEO David Hallal and CFO Vikas Sinha have resigned effective immediately in connection with …
News
jevtana_0

Scottish Medicines Consortium approves Sanofi’s prostate cancer drug

December 12, 2016 Manufacturing and Production, Sales and Marketing Jevtana, Sanofi, prostate cancer

Sanofi’s speciality care global business unit Sanofi Genzyme has announced that the Scottish Medicines Consortium has accepted the company’s Jevtana …
News
emma-harvey0006_horizontal

Rare challenges: Meeting patient needs and delivering medical innovation in ultra-rare diseases

December 12, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, ultra rare disease, ultra-rare disease

Dr Emma Harvey, ‎senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the …
Feature
astrazeneca_plaque

AZ to terminate 700 US jobs

December 9, 2016 Manufacturing and Production, Medical Communications AstraZeneca, job cuts

AstraZeneca has revealed that it plans to cut 700 positions across the US by 10 February 2017, including 120 positions …
News
china_pic

Top Pharmaceutical Markets 2016: China

December 9, 2016 Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing China, market analysis

Originally featured in Pharmafile Autumn 2016, a report from the United States International Trade Administration sheds light on the Chinese …
News
sicorbio

Teva embroiled in internal bribery investigation

December 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, bribery

Israeli pharmaceutical firm Teva has confirmed it is embroiled in an ongoing internal investigation into allegations of bribery, after the …
News

Mylan to restructure and slash around 10% of workforce

December 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses

Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …
News
lisa_anson

AstraZeneca’s Lisa Anson appointed president of ABPI

December 7, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lisa Anson, current president of AstraZeneca UK & Ireland, has been appointed to the position of president of ABPI. Lisa …
Appointment
shire_image

Shire given permission for $400 million biologics manufacturing facility

December 6, 2016 Manufacturing and Production, Research and Development Co Meat, Ireland, Shire

Shire has received planning permission for a new state-of-the-art biologics manufacturing facility in Co Meath, Ireland. The plant will be …
News
jake_dupont

CMO of OncoMed Pharma resigns

December 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OncoMed Pharmaceuticals, a clinical-stage pharmaceutical company, announced that Jakob Dupont has resigned from his positions as the company’s senior vice …
Appointment
sigurdur_olaffson_teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
Appointment
gwpharma

Cannabis-based treatment scores Phase 3 successes for GW Pharma

December 6, 2016 Manufacturing and Production, Research and Development GW Pharma, cannabidiol

UK-based GW Pharmaceuticals, a biopharmaceutical firm focused on the development of novel cannabinoid therapies, has unveiled new efficacy data for …
News
teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016 Manufacturing and Production, Medical Communications Teva, generics

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026